Web Stats Provided By Google Analytics

Showing posts with label Research and Markets: PharmaPoint: HIV - Japan Drug Forecast and Market Analysis to 2022. Show all posts
Showing posts with label Research and Markets: PharmaPoint: HIV - Japan Drug Forecast and Market Analysis to 2022. Show all posts

Monday, June 24, 2013

Research and Markets: PharmaPoint: HIV - Japan Drug Forecast and Market Analysis to 2022

... of lives since its emergence. However, the advent of antiretroviral therapy (ART) has transformed the face of HIV/AIDS from a deadly disease to a manageable chronic condition for most infected individuals. Antiretroviral treatment not only reduces ...

http://it.tmcnet.com/news/2013/06/24/7225835.htm

Research and Markets: PharmaPoint: HIV - Japan Drug Forecast and Market Analysis to 2022

... of lives since its emergence. However, the advent of antiretroviral therapy (ART) has transformed the face of HIV/AIDS from a deadly disease to a manageable chronic condition for most infected individuals. Antiretroviral treatment not only reduces ...

http://www.businesswire.com/news/topix/20130624005597/en